WO1997012598A3 - Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin - Google Patents

Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin Download PDF

Info

Publication number
WO1997012598A3
WO1997012598A3 PCT/IT1996/000184 IT9600184W WO9712598A3 WO 1997012598 A3 WO1997012598 A3 WO 1997012598A3 IT 9600184 W IT9600184 W IT 9600184W WO 9712598 A3 WO9712598 A3 WO 9712598A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
dermatological
topical application
cosmetic compositions
compositions suitable
Prior art date
Application number
PCT/IT1996/000184
Other languages
French (fr)
Other versions
WO1997012598A2 (en
Inventor
Simone Claudio De
Original Assignee
Mendes Srl
Prex Srl
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendes Srl, Prex Srl, Simone Claudio De filed Critical Mendes Srl
Publication of WO1997012598A2 publication Critical patent/WO1997012598A2/en
Publication of WO1997012598A3 publication Critical patent/WO1997012598A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

The use of growth factors such as granulocyte-monocyte colony stimulating factor and macrophage colony stimulating factors is disclosed for producing dermatological and cosmetic compositions suitable for topical application, endowed with a modulating effect on the endogenous ceramides of the skin.
PCT/IT1996/000184 1995-10-06 1996-10-03 Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin WO1997012598A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM95A000662 1995-10-06
IT95RM000662A IT1276213B1 (en) 1995-10-06 1995-10-06 DERMATOLOGICAL AND COSMETIC COMPOSITIONS SUITABLE FOR TOPICAL APPLICATION, WITH A MODULATING EFFECT ON THE ENDOGENOUS CERAMIDS OF THE EPIDERMIS

Publications (2)

Publication Number Publication Date
WO1997012598A2 WO1997012598A2 (en) 1997-04-10
WO1997012598A3 true WO1997012598A3 (en) 1997-05-15

Family

ID=11403598

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT1996/000184 WO1997012598A2 (en) 1995-10-06 1996-10-03 Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin

Country Status (2)

Country Link
IT (1) IT1276213B1 (en)
WO (1) WO1997012598A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002807B (en) 1996-06-20 1997-11-13 Lavipharm A.E. Device for topical treatment of acne and method of manufacture.
AU3837300A (en) * 1999-04-15 2000-11-02 Takara Shuzo Co., Ltd. Remedies
CN107405305B (en) * 2015-01-20 2020-12-25 泰特拉德姆集团有限责任公司 Universal topical drug delivery vehicle and multifactorial tissue moisturizer providing mucosal and skin barrier restoration

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261599A2 (en) * 1986-09-26 1988-03-30 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
WO1990006743A1 (en) * 1988-12-21 1990-06-28 Genetics Institute, Inc. Method for restoring hair growth
EP0456842A1 (en) * 1989-12-13 1991-11-21 Otsuka Pharmaceutical Co., Ltd. Medicinal application of m-csf
JPH0477434A (en) * 1990-07-17 1992-03-11 Kanji Takada Preparation of granulocyte colony stimulation factor to be applied to ocular mucous membrane
WO1992014480A1 (en) * 1991-02-22 1992-09-03 Amgen Inc. Use of gm-csf and g-csf to promote accelerated wound healing

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261599A2 (en) * 1986-09-26 1988-03-30 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
WO1990006743A1 (en) * 1988-12-21 1990-06-28 Genetics Institute, Inc. Method for restoring hair growth
EP0456842A1 (en) * 1989-12-13 1991-11-21 Otsuka Pharmaceutical Co., Ltd. Medicinal application of m-csf
JPH0477434A (en) * 1990-07-17 1992-03-11 Kanji Takada Preparation of granulocyte colony stimulation factor to be applied to ocular mucous membrane
WO1992014480A1 (en) * 1991-02-22 1992-09-03 Amgen Inc. Use of gm-csf and g-csf to promote accelerated wound healing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 117, no. 6, 10 August 1992, Columbus, Ohio, US; abstract no. 56033, XP002027505 *
MEMISOGLU E. ET AL.: "wound healing effectiveness of rHuGM-CSFfrom different topical formulations", FACULTY PHARMACY, HACETTEPE UNIV.,ANKARA *
WORLD MEET. PHARM. BIOPHARM. TECHNOL., no. 1, 1995, APGI,CHATENAY MALABRY, FR, pages 742 - 3, XP000645571 *

Also Published As

Publication number Publication date
IT1276213B1 (en) 1997-10-27
WO1997012598A2 (en) 1997-04-10
ITRM950662A0 (en) 1995-10-06
ITRM950662A1 (en) 1997-04-06

Similar Documents

Publication Publication Date Title
CA2316826A1 (en) Reduction of hair growth
CA2237979A1 (en) Reduction of hair growth
CA2200851A1 (en) Inhibition of hair growth
CA2184171A1 (en) Inhibition of Hair Growth
CA2184173A1 (en) Inhibition of Hair Growth
CA2385006A1 (en) Reduction of hair growth
CA2252900A1 (en) Cosmetic composition for rejuvenation of skin without skin irritation
AU7382096A (en) Stimulation of hair follicles
CA2163535A1 (en) Inhibition of hair growth
CA2086429A1 (en) Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol
CA2077144A1 (en) Cosmetic Composition
EP2020228A3 (en) Skin cosmetic composition
AU3313593A (en) Embossed facial tissue
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
CA2347975A1 (en) Reduction of hair growth
AU6124796A (en) Appliance for the epilation of the human skin
HK1024636A1 (en) Use of sphingomyelinase for producing dermatological and cosmetic compositions for increasing the levels of skin and mucosal ceramides
CA2304807A1 (en) Reduction of hair growth
AU4028395A (en) Cosmetic or dermatological composition in the form of a water-in-oil emulsion with a high content of hydroxy acids
CA2311756A1 (en) Reduction of hair growth
CA2168518A1 (en) Cosmetic compositions for reducing or preventing signs of cellulite
WO1996001613A3 (en) Alcoholic moisturizing after shave lotion
AU3588797A (en) Enhancement of skin pigmentation by prostaglandins
CA2207783A1 (en) Antiperspirant or deodorant composition comprising a moisturizing cream
CA2245206A1 (en) Use of an inhibitor of excitatory amino acids in a cosmetic or dermatological compound for sensitive skin, and the compound thus obtained

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97514127

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase